Download PDF
Synfacts 2022; 18(09): 1025
DOI: 10.1055/s-0041-1738304
Innovative Drug Discovery and Development

Synthesis of Danuglipron: An Orally Available GLP-1R Agonist

Authors

    Contributor(s):

  • Antonia F. Stepan (Roche)

  • Ferdinand H. Lutter (Janssen Pharmaceutica)

Further Information
  Permissions and Reprints
Preview

Key words

danuglipron - Buchwald–Hartwig etherification - benzimidazoles - chemoselective saponification - antidiabetics - PF-06882961


Publication History

Article published online:
18 August 2022

© 2022. Thieme. All rights reserved

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany